Jill Feldman: New Research Explores the Genetics Behind Familial Lung Cancer
New research involving over 3.3 million people has provided deeper insights into the rare inherited EGFR T790M mutation linked to lung cancer. The study aims to improve early detection and screening protocols for those at genetic risk.
Why it matters
Advancements in genetic screening for lung cancer are critical for improving patient survival rates through earlier intervention.
Jill Feldman , Co-Founder at EGFR Resisters, shared on X :
“New research deepens our understanding of inherited lung cancer risk. Researchers analyzed genetic data from 3.3M+ people to better understand germline EGFR T790M , a rare inherited mutation.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in